Cargando…

Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections

BACKGROUND: The aim of the present study was to develop a simple, portable, and rapid assay for serodiagnosis of toxoplasmosis based on recombinant Toxoplasma gondii (T. gondii) SAG1 (rSAG1) and GRA7 (rGRA7) proteins. METHODS: The rSAG1 and rGRA7 proteins were expressed in Escherichia coli (E. coli)...

Descripción completa

Detalles Bibliográficos
Autores principales: Teimouri, Aref, Modarressi, Mohammad Hossein, Shojaee, Saeedeh, Mohebali, Mehdi, Rezaian, Mostafa, Keshavarz, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717716/
https://www.ncbi.nlm.nih.gov/pubmed/31695442
http://dx.doi.org/10.2147/IDR.S219281
_version_ 1783447597360349184
author Teimouri, Aref
Modarressi, Mohammad Hossein
Shojaee, Saeedeh
Mohebali, Mehdi
Rezaian, Mostafa
Keshavarz, Hossein
author_facet Teimouri, Aref
Modarressi, Mohammad Hossein
Shojaee, Saeedeh
Mohebali, Mehdi
Rezaian, Mostafa
Keshavarz, Hossein
author_sort Teimouri, Aref
collection PubMed
description BACKGROUND: The aim of the present study was to develop a simple, portable, and rapid assay for serodiagnosis of toxoplasmosis based on recombinant Toxoplasma gondii (T. gondii) SAG1 (rSAG1) and GRA7 (rGRA7) proteins. METHODS: The rSAG1 and rGRA7 proteins were expressed in Escherichia coli (E. coli) and purified in a single step by immobilized metal ion affinity chromatography. The immunoreactivity of the recombinant antigens was tested in an in-house IgG and IgM Dot enzyme-linked immunosorbent assay (Dot-ELISA) for potential use in serodiagnosis of T. gondii infection. RESULTS: Results from the comparison of in-house rSAG1-Dot-ELISA with ELISA for the detection of anti-Toxoplasma IgG and IgM include sensitivity of 83.7% and 81.2%, specificity of 90.2% and 89.3%, positive predictive values of 85.9% and 68.4%, and negative predictive values of 88.6% and 94.3%, respectively. Sensitivity of 66.2%, specificity of 81.2%, positive predictive values of 71.6%, and negative predictive values of 77.1% were concluded from in-house IgG rGRA7-Dot-ELISA. The sensitivity and specificity of IgM rGRA7-Dot-ELISA included 87.5% and 83.9%, respectively. Sensitivity and specificity of in-house Dot-ELISA for a combination of rSAG1 and rGRA7 included 87.5% and 91.1% for IgG and IgM, respectively. Sensitivity and specificity of a combination of rSAG1 and rGRA7 for the detection of IgM in suspected sera to acute toxoplasmosis were higher than those for the detection of IgG in sera with chronic infections (90.6% and 92% instead of 86.2% and 91.6%, respectively). CONCLUSION: The highlighted parameters of combined recombinant proteins were more significant than those of single recombinant proteins in in-house Dot-ELISA. These data suggest that the in-house Dot-ELISA based on rSAG1 and rGRA7 combination is a promising diagnostic tool with a similar sensitivity to the native antigens of T. gondii, which can be used for the serodiagnosis of toxoplasmosis in fields as well as less equipped laboratories.
format Online
Article
Text
id pubmed-6717716
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67177162019-11-06 Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections Teimouri, Aref Modarressi, Mohammad Hossein Shojaee, Saeedeh Mohebali, Mehdi Rezaian, Mostafa Keshavarz, Hossein Infect Drug Resist Original Research BACKGROUND: The aim of the present study was to develop a simple, portable, and rapid assay for serodiagnosis of toxoplasmosis based on recombinant Toxoplasma gondii (T. gondii) SAG1 (rSAG1) and GRA7 (rGRA7) proteins. METHODS: The rSAG1 and rGRA7 proteins were expressed in Escherichia coli (E. coli) and purified in a single step by immobilized metal ion affinity chromatography. The immunoreactivity of the recombinant antigens was tested in an in-house IgG and IgM Dot enzyme-linked immunosorbent assay (Dot-ELISA) for potential use in serodiagnosis of T. gondii infection. RESULTS: Results from the comparison of in-house rSAG1-Dot-ELISA with ELISA for the detection of anti-Toxoplasma IgG and IgM include sensitivity of 83.7% and 81.2%, specificity of 90.2% and 89.3%, positive predictive values of 85.9% and 68.4%, and negative predictive values of 88.6% and 94.3%, respectively. Sensitivity of 66.2%, specificity of 81.2%, positive predictive values of 71.6%, and negative predictive values of 77.1% were concluded from in-house IgG rGRA7-Dot-ELISA. The sensitivity and specificity of IgM rGRA7-Dot-ELISA included 87.5% and 83.9%, respectively. Sensitivity and specificity of in-house Dot-ELISA for a combination of rSAG1 and rGRA7 included 87.5% and 91.1% for IgG and IgM, respectively. Sensitivity and specificity of a combination of rSAG1 and rGRA7 for the detection of IgM in suspected sera to acute toxoplasmosis were higher than those for the detection of IgG in sera with chronic infections (90.6% and 92% instead of 86.2% and 91.6%, respectively). CONCLUSION: The highlighted parameters of combined recombinant proteins were more significant than those of single recombinant proteins in in-house Dot-ELISA. These data suggest that the in-house Dot-ELISA based on rSAG1 and rGRA7 combination is a promising diagnostic tool with a similar sensitivity to the native antigens of T. gondii, which can be used for the serodiagnosis of toxoplasmosis in fields as well as less equipped laboratories. Dove 2019-08-27 /pmc/articles/PMC6717716/ /pubmed/31695442 http://dx.doi.org/10.2147/IDR.S219281 Text en © 2019 Teimouri et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Teimouri, Aref
Modarressi, Mohammad Hossein
Shojaee, Saeedeh
Mohebali, Mehdi
Rezaian, Mostafa
Keshavarz, Hossein
Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections
title Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections
title_full Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections
title_fullStr Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections
title_full_unstemmed Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections
title_short Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections
title_sort development, optimization, and validation of an in-house dot-elisa rapid test based on sag1 and gra7 proteins for serological detection of toxoplasma gondii infections
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717716/
https://www.ncbi.nlm.nih.gov/pubmed/31695442
http://dx.doi.org/10.2147/IDR.S219281
work_keys_str_mv AT teimouriaref developmentoptimizationandvalidationofaninhousedotelisarapidtestbasedonsag1andgra7proteinsforserologicaldetectionoftoxoplasmagondiiinfections
AT modarressimohammadhossein developmentoptimizationandvalidationofaninhousedotelisarapidtestbasedonsag1andgra7proteinsforserologicaldetectionoftoxoplasmagondiiinfections
AT shojaeesaeedeh developmentoptimizationandvalidationofaninhousedotelisarapidtestbasedonsag1andgra7proteinsforserologicaldetectionoftoxoplasmagondiiinfections
AT mohebalimehdi developmentoptimizationandvalidationofaninhousedotelisarapidtestbasedonsag1andgra7proteinsforserologicaldetectionoftoxoplasmagondiiinfections
AT rezaianmostafa developmentoptimizationandvalidationofaninhousedotelisarapidtestbasedonsag1andgra7proteinsforserologicaldetectionoftoxoplasmagondiiinfections
AT keshavarzhossein developmentoptimizationandvalidationofaninhousedotelisarapidtestbasedonsag1andgra7proteinsforserologicaldetectionoftoxoplasmagondiiinfections